Mode
Text Size
Log in / Sign up

Suicidal Ideation

Part of Suicide

11 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Suicidal Ideation

56 trials tracked for Suicidal Ideation: 11 in phase 3 or 4 and 6 with published results. The most-cited published study has 428 citations.

56Trials tracked
11Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 10 Phase 3 1 Phase 2 2 Other / NA 43
  1. Phase 4 Ketamine in the Treatment of Suicidal Depression Completed · 428 cited
  2. Phase 4 Ketamine For Suicidal Ideation Completed · 297 cited
  3. Phase 4 Reducing Suicidal Ideation Through Insomnia Treatment Completed · 152 cited
  4. Phase 4 Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality Completed · 42 cited
  5. Phase 3 Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse Completed · 13 cited
  6. Phase 4 Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality Completed
Show 44 more trials
  1. Phase 4 Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study Completed
  2. Phase 4 Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD) Completed
  3. Phase 4 Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation Completed
  4. Phase 4 Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach Completed
  5. Phase 4 Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation Completed
  6. Phase 2 Ketamine for Suicidality in Bipolar Depression Completed
  7. Phase 2 Sequential Therapy for the Treatment of Severe Bipolar Depression. Completed
  8. N/A Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults Completed
  9. N/A Career Enhancement Training Study (USAF) Completed
  10. N/A Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens) Completed
  11. N/A Mobile Technology for Reducing and Preventing Adolescent Suicide Completed
  12. N/A Text 2 Connect- Texting Intervention for Mental Health Treatment Utilization Completed
  13. N/A Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI) Completed
  14. N/A RCT of Brief CBT-I in Primary Care Veterans With Suicidal Thoughts Completed
  15. N/A Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders Completed
  16. N/A BRITEPath- Phase 2 Completed
  17. N/A A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Completed
  18. N/A Dialectical Behavior Therapy Skills Group Pilot Evaluation Completed
  19. N/A Drivers of Suicide Mobile App Study Completed
  20. N/A Improving Treatment Outcomes for Suicidal Veterans With PTSD Completed
  21. N/A A Trauma-Informed Approach for Positive Youth Development for Montana Students Completed
  22. N/A Navigating Mental Health Treatment for Black Youth Completed
  23. N/A Screening Wizard- Phase 2 Completed
  24. N/A Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms Completed
  25. N/A Treatment of Suicidal Ideation With Intravenous Ketamine Infusion Completed
  26. N/A Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk Completed
  27. N/A Skills to Enhance Positive Affect in Suicidal Adolescents Completed
  28. N/A A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot Completed
  29. N/A Social Connections and Late Life Suicide Completed
  30. N/A BRITEPath, Component 3 of iCHART (Integrated Care to Help At-Risk Teens) Completed
  31. N/A Safety Planning in Juvenile Justice for Suicidal Youth Completed
  32. N/A Written vs Electronic Safety Planning Study Completed
  33. N/A UH3 Pragmatic Suicide Prevention Trial Completed
  34. N/A Engaging Black Youth in Depression and Suicide Prevention Treatment Within Urban Schools Completed
  35. N/A Pilot RCT of a Video-based Intervention for Suicide Prevention Completed
  36. N/A Observational Study to Compare Outcomes of Different Psychiatric Treatment of Suicidal Adolescents Completed
  37. N/A Virtual Hope Box - Effectiveness of a Smartphone App for Coping With Suicidal Ideation Completed
  38. N/A Computer Assisted Family Intervention to Treat Self-Harm Disparities in Latinas and Sexual/Gender Minority Youth Completed
  39. N/A Screening Wizard, Component 1 of iCHART (Integrated Care to Help At-Risk Teens)-Feasibility/Pilot Phase Completed
  40. N/A Digital Mental Health Service for Non-Treatment Seeking Young Adults Completed
  41. N/A Group Depression Treatment for Autistic Youth Completed
  42. N/A Motivational Interviewing to Prevent Suicide in High Risk Veterans Completed
  43. N/A The Elders' Resilience Curriculum Completed
  44. N/A TMS for Suicidal Crisis in Active Duty SMs Completed

Showing the 50 most-cited and recently-updated of 56 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Suicidal Ideation: what the trials found

Ketamine has been shown to reduce suicidal ideation. In a phase 4 trial (N=82), ketamine was associated with a significant reduction in Beck Scale for Suicidal Ideation (BSSI) scores compared to placebo (p=0.047) 6. Another trial (N=24) reported a change in BSSI from 8.8 to 15.3 (p=0.047) 6. Intranasal ketamine was also studied (N=33) and assessed for manic symptoms and dissociative state, but no direct comparison for suicidal ideation was provided 15. Additional trials (N=16) further support ketamine's use 17.

Estradiol transdermal patch (0.1 mg/24 hrs) has demonstrated efficacy in reducing perimenstrual suicidal ideation. In a trial (N=30), perimenstrual change in Suicidal Ideation Score (SITBI) was significantly reduced (p=.012) 8. Another trial (N=124) showed significant reduction in perimenstrual Daily Adult Suicidal Ideation Questionnaire (ASIQ) scores (p<.001) and Columbia Suicide Severity Rating Scale (C-SSRS) planning item scores (p=.026) 9. A third trial (N=60) found significant cyclical change in suicidal ideation severity (p=.002) with transdermal estradiol plus placebo 11.

Other interventions have been studied with mixed or limited evidence. Paliperidone (N=54) showed no significant difference in Beck Scale for Suicidal Ideation scores compared to lithium or placebo after 3 months (mean scores 22.1, 22.1, 21.3) 14. Paroxetine CR (N=15) was associated with a reduction in SSI score from 11 to 0.3 13. Prazosin (N=20) showed a change score of 7.6 to 8.2 on the Scale for Suicide Ideation 12. Zolpidem-CR (N=103) and uridine (N=75) were studied but no specific outcomes for suicidal ideation were reported 710.

Recent results — preliminary, needs further review

  • Adapted STAT-ED (N=54) is being investigated for suicidal ideation 1.
  • WisePath for Adults (N=127) is a recent intervention under study 2.
  • BE-SMART-DR (N=65) showed significant reductions in suicidal ideation/propensity as measured by CHRT-SR (p=0.0008) and SSI (p<.0001), and improved daily rhythms (p=0.0002) 3.
  • Adaptive messaging intervention (N=120) is being explored 4.
  • Making Connections Intervention (N=29) is a recent approach 18.

For the clinician treating this condition

  • Ketamine and estradiol transdermal patch have established evidence for reducing suicidal ideation in specific populations.
  • Paliperidone and prazosin showed no significant benefit over comparators for suicidal ideation.
  • Recent interventions like BE-SMART-DR show promise but require further corroboration.

AI synthesis of 16 cited trials, updated Jun 28, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.